Does Andthiazide Interact with Levalbuterol Hydrochloride?
CDI records a moderate classification for Andthiazide and Levalbuterol Hydrochloride. The stored summary is: May worsen ECG changes or hypokalemia. Consider monitoring potassium levels during coadministration. The mechanism involves potassium-wasting effects potentiated by beta-agonists. Patients taking both medications should consult their healthcare provider before starting, stopping, or changing the dosage of either drug. This record was extracted from drug labeling through openFDA. NIH/NLM RxNorm is used for drug identities. The summary and severity classification are CDI's processed information, not a verbatim source quotation. Product, route, and patient circumstances matter.
- Severity
- Moderate
- Management
- Monitor for effects
- Data Source
- U.S. FDA via OpenFDA
Recorded Mechanism
Potassium-wasting effects potentiated by beta-agonists
What To Tell Your Doctor or Pharmacist
If you are taking Andthiazide and your doctor is considering prescribing Levalbuterol Hydrochloride (or vice versa), make sure to:
- Inform your doctor and pharmacist of all current medications, including over-the-counter drugs and supplements
- Ask whether the benefits of combining these medications outweigh the risks for your specific situation
- Ask what symptoms to watch for that would indicate the interaction is causing problems
- Ask whether any dosage adjustments are needed
- Never stop or change either medication without first consulting your healthcare provider